ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,142.15
-0.06%
Dow Jones
38,778.10
0.49%
Gold vs US Dollar
2,323.22
0.12%
Brent Oil
83.635
-0.32%
Bitcoin
65,582.09
-1.36%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Supernus Pharmaceuticals Inc (SUPN) Share Price

SUPN Supernus Pharmaceuticals Inc

25.99
0.00 (0.00%)
18 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Supernus Pharmaceuticals Inc NASDAQ:SUPN NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 25.99 14.44 40.00 26.52 25.82 25.82 432,597 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 609.04M 1.32M 0.0240 1082.92 1.42B
 Type  Size  Price  Time  Units 
 16 206 25.99 20:20:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SUPN News
17/06/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee benefit plans
17/06/202421:15EDGAR2Form 8-K - Current report
30/05/202421:25GLOBESupernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
23/05/202421:25EDGAR2Form 8-K - Current report
23/05/202421:05GLOBESupernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
09/05/202421:09EDGAR2Form 8-K - Current report
09/05/202421:05GLOBESupernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
Period
Draw mode
Data Downloads for SUPN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Supernus Pharmaceuticals Inc Articles